Search Tag: Board of Directors
2023 23 Mar
AVITA Medical, Inc., a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous cellular therapies for skin restoration, announced today the appointment of Robert McNamara to its Board of Directors, effective April 1, 2023. Mr. McNamara is an accomplished senior executive with over...Read more
2023 17 Mar
Vanda Pharmaceuticals Inc. announced the appointment of Tage Honoré, Ph.D., D.Sc. to its Board of Directors effective March 15, 2023 . Following Dr. Honoré's appointment, Vanda's Board of Directors is now comprised of six directors, five of whom are independent. "Tage is a highly accomplished industry leader and respected scientist with deep...Read more
2023 14 Mar
Aashima Gupta has over 25 years’ experience of growing, differentiating, and enhancing businesses through technology transformation within banking and MedTech. In her current position as Global Director of Healthcare Industry Solutions at Google Cloud, Aashima has an illustrious track record in accelerating Google Cloud’s Healthcare industry...Read more
2023 10 Mar
Diamyd Medical announced that Karin Rosén, M.D, Ph.D, San Francisco, will join the Board of Directors as an adjunct member, and be proposed for election to the Board at its next General Meeting of Shareholders. Dr. Rosén has deep experience from the biotechnology industry with more than two decades of working in senior leadership positions in global...Read more
2023 21 Feb
The American Brain Tumor Association announced the appointment of Ram Subramanian as Chair of the Board of Directors, and newly-elected Member Srisupen Andersen, CFA. Their terms began on January 1, 2023. In his new role as Board Chair, Ram Subramanian is responsible for leading the ABTA’s Board of Directors, which provides strategic governance...Read more
2023 14 Feb
KeifeRx, an emerging clinical-stage biopharmaceutical company specializing in the discovery and development of new treatment options for neurodegenerative and immune diseases, announced the appointment of Garrett Vygantas, MD, MBA, to serve on the Company's Board of Directors. Dr. Vygantas brings more than 20 years of industry, investment and...Read more
2023 28 Jan
Kathleen M. Ferket, MSN, Principal and Founding Member of L3 Advisors Group, and Joianne L. Smith, PhD, President and Chief Executive Officer of Oakton College, have been appointed to NorthShore University HealthSystem’s (NorthShore’s) Board of Directors. The board is one of four community-focused boards central to NorthShore – Edward-Elmhurst Health’s...Read more
2023 27 Jan
New Members Bring Deep Experience in Advanced Technology and Global Health Inteleos, a non-profit global healthcare certification organization announced the appointment of Vera M. Zlidar and Neil Sahota to its board of directors effective January 1. Zlidar serves the board with expertise in global health focusing on maternal fetal healthcare....Read more
2023 23 Jan
Akston Biosciences Corporation, a clinical-stage biotechnology company announced that John T. Preston, a founder of TEM Capital , has joined its Board of Directors. A recipient of numerous awards and previous advisor to several government agencies and expert witness for Congress, Preston brings to Akston his decades of experience in technology commercialization...Read more
2023 09 Jan
AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications announced that CEO Dr. Hans Keirstead has joined the board of the esteemed Human Immunome Project. Modeled after the Human Genome Project, the Human Immunome Project is a 501(c)(3) nonprofit organization focused on global scientific collaboration to decode...Read more
2023 05 Jan
Provention Bio, Inc., a biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases announced the appointment of Rita Jain , M.D., to the Company's Board of Directors. Dr. Jain is a biotechnology industry veteran with more than two decades of experience in pharmaceutical development across her time with ChemoCentryx,...Read more
2022 29 Dec
Viatris Inc. a global healthcare company announced that Scott A. Smith and Elisha W. Finney have been appointed as Viatris' newest members of its board of directors. Smith and Finney fill the vacancies created by the retirement of Neil Dimick and Ian Reid . Scott Smith is a deeply experienced global biotechnology and pharmaceutical executive...Read more
2022 15 Dec
Codagenix Inc., a clinical-stage synthetic biology company with a rational virus design platform for viral vaccines and immuno-oncology therapeutics announced that Paul Grint, MD, has been appointed Chairman of the Board of Directors. “We are delighted to welcome Paul to our Board of Directors. He is a biotechnology industry veteran who brings...Read more
2022 21 Nov
VYRSA Technologies, Inc., a specialty medical device company specializing in innovative sacroiliac fusion devices, announced that, effective November 1, 2022, Earl R. Fender has been appointed to the Board of Directors. Fender previously served as the President & CEO of Nalu from 2020 to 2022 and as President & CEO of Vertiflex, Inc. from...Read more
2022 17 Nov
Nanostics Inc., a precision health diagnostics company announced the appointment of Aubrey Rankin to its Board of Directors. Mr. Rankin will join the board of directors at Nanostics replacing Mr. Reg Joseph as one of the independent directors for the company. "We're excited to announce Aubrey Rankin's appointment to Nanostics' Board of Directors....Read more
2022 16 Nov
Centene Corporation announced that it has appointed Monte Ford to the Centene Board of Directors, effective November 12th. Mr. Ford is a leading technologist with more than 20 years of board experience serving Fortune 500 companies across a wide spectrum of industries. He currently sits on the boards of JetBlue Airways, Iron Mountain and Akamai...Read more
2022 16 Nov
Board Includes Co-Chairmen John Arlotta and Bill Valle, as well as Alex Azar, former U.S. Secretary of Health and Human Services, and Gina Loften, former Chief Technology Officer of Microsoft U.S. Interwell Health , a physician-centered organization dedicated to reimagining kidney care, today announced the appointment of eight leaders to its...Read more
2022 11 Nov
The National Kidney Foundation (NKF) is pleased to announce that Dr. Kirk Campbell , the Irene and Dr. Arthur M. Fishberg Professor of Medicine at the Icahn School of Medicine at Mount Sinai and Vice Chair of the Department of Medicine for Diversity, Equity, and Inclusion, has begun his two-year term as President Elect of NKF’s National Board...Read more
2022 03 Nov
HSI is excited to announce that Nancy Schlossberg and Barbara Strain have joined the Healthcare Surfaces Institute board of directors. “Ms. Schlossberg and Ms. Strain have unique areas of expertise that will bring tremendous value to our organization,” said Linda Lybert, executive director of HSI. “They also share our organization's deep commitment...Read more
2022 03 Nov
Elucid, Inc ., a leading medical technology company providing physicians with AI-powered imaging analysis software to characterize cardiovascular disease, today announced the addition of Michael D. Lesh, MD, FACC, to its Board of Directors. “We look forward to what Dr. Lesh will bring to the board with his extensive background as a cardiologist,...Read more
2022 20 Oct
The Board of Directors for Bridge to Life, a world leader in organ preservation, announced Don Webber as the new President and Chief Executive Officer. Webber’s appointment comes after Steve Schweighardt, founder, and former CEO for over seventeen years, announced his retirement from daily operations. Schweighardt will remain as Chairman. In making...Read more
2022 18 Oct
Leading expert in alopecia, Dr. Brett King brings deep academic insight and drug development experience to help BiologicsMD advance its innovative hair and bone therapies BiologicsMD , a preclinical therapeutic development company focused on highly-targeted treatments for hair loss and bone disorders, announced the appointment of Brett King,...Read more
2022 12 Oct
Geneos Therapeutics, a clinical stage biotherapeutics company focused on the development of personalized therapeutic cancer vaccines (PTCV) announced that the company has expanded its leadership team and has elected Dr. Laurent Humeau to the company's board of directors. "As we approach an important clinical data announcement from our ongoing...Read more
2022 12 Oct
HealthManagement.org is proud to welcome Rita Veloso as our new regional ambassador Veloso is an executive member of the Board of Directors of Centro Hospitalar Universitário do Porto. Until 2021, Veloso served as an executive member of the Board of Directors of Póvoa de Varzim and Vila do Conde Hospital Center. She has been part...Read more
2022 06 Oct
Nuvalent, Inc, a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer announced the appointment of Michael L. Meyers , M.D., Ph.D., to its Board of Directors. An experienced drug developer and medical oncologist who has contributed to the successful development and...Read more
2022 06 Oct
Mallinckrodt plc, a global specialty pharmaceutical company announced that it has appointed Susan Silbermann to its Board of Directors, effective October 5, 2022 . With the addition of Ms. Silbermann, the Mallinckrodt Board will expand to nine directors, eight of whom are independent. "Susan is a highly respected and deeply experienced global...Read more
2022 05 Oct
Precision medicine company adds a suite of new board members and advisors to guide the company in accelerating the growth of its precision medicine solutions for acute care Prenosis, Inc. , a precision medicine company announced four new members to its Board of Directors and nine members to its Clinical & Scientific Board. The academic and...Read more
2022 04 Oct
R-Zero, a global leader in biosafety technology announced that its Board of Directors has appointed Jennifer Nuckles as Chief Executive Officer and the Chair of the company’s Board of Directors, effective October 10. “Jennifer is a perfect fit to lead R-Zero in the next chapter of scaling the business,” said Ira Ehrenpreis, Founder and Managing...Read more
2022 29 Sep
Artivion, Inc., a leading cardiac and vascular surgery company focused on aortic disease announced the appointment of Elizabeth A. Hoff to its Board of Directors effective October 1, 2022. "We are excited to welcome Elizabeth to our Board of Directors," said Pat Mackin, Chairman, President, and Chief Executive Officer. "Elizabeth brings a wealth...Read more
2022 26 Sep
TISSIUM, a privately-owned medtech company developing biomorphic programmable polymers for tissue reconstruction announced it has appointed Sara Toyloy as its fourth independent member of the Board of Directors. Ms. Toyloy has over 30 years of experience in the medical device industry. In 2020, she founded Fabrica Consulting LLC, a medical device...Read more